Ran Xue

1.1k total citations
35 papers, 697 citations indexed

About

Ran Xue is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Ran Xue has authored 35 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 14 papers in Hepatology and 11 papers in Molecular Biology. Recurrent topics in Ran Xue's work include Liver Disease Diagnosis and Treatment (10 papers), Liver Disease and Transplantation (10 papers) and Mitochondrial Function and Pathology (4 papers). Ran Xue is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Liver Disease and Transplantation (10 papers) and Mitochondrial Function and Pathology (4 papers). Ran Xue collaborates with scholars based in China, Ethiopia and United States. Ran Xue's co-authors include Qinghua Meng, Jianyu Hao, Jing Wu, Yanbin Wang, Jianxin Wang, Shenshen Zhang, Jing Yang, Lingyun Gao, Kai Jia and Xingwei Xiang and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and British Journal of Cancer.

In The Last Decade

Ran Xue

35 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ran Xue China 16 258 171 150 129 117 35 697
Karen M. Kassel United States 15 268 1.0× 369 2.2× 113 0.8× 142 1.1× 92 0.8× 20 800
Qianqian Tu China 9 180 0.7× 300 1.8× 215 1.4× 102 0.8× 81 0.7× 12 640
Yan–Xin Chang China 12 355 1.4× 288 1.7× 183 1.2× 105 0.8× 81 0.7× 17 820
Yoshinobu Saito Japan 14 283 1.1× 409 2.4× 91 0.6× 105 0.8× 57 0.5× 34 754
Benita L. McVicker United States 18 216 0.8× 277 1.6× 73 0.5× 87 0.7× 56 0.5× 50 788
Maximilian Hatting Germany 15 464 1.8× 344 2.0× 158 1.1× 161 1.2× 80 0.7× 22 1.0k
Chengyong Tang China 12 319 1.2× 140 0.8× 84 0.6× 109 0.8× 63 0.5× 21 695
Hanyong Sun China 13 413 1.6× 356 2.1× 203 1.4× 171 1.3× 210 1.8× 21 1.0k
Simon M. Schultze Switzerland 5 380 1.5× 167 1.0× 153 1.0× 84 0.7× 89 0.8× 6 697

Countries citing papers authored by Ran Xue

Since Specialization
Citations

This map shows the geographic impact of Ran Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Xue more than expected).

Fields of papers citing papers by Ran Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Xue. The network helps show where Ran Xue may publish in the future.

Co-authorship network of co-authors of Ran Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Xue. A scholar is included among the top collaborators of Ran Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Xue. Ran Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jiarui, Min Tao, Lian Liu, et al.. (2025). Peripheral blood neutrophils contribute to Claudin18.2-specific CAR-T cell treatment resistance in advanced gastric cancer. British Journal of Cancer. 132(12). 1167–1176. 2 indexed citations
2.
Cheng, Chao, et al.. (2022). Recharacterization of superior limbic keratoconjunctivitis via a subdividing grading method in 236 Chinese patients. Graefe s Archive for Clinical and Experimental Ophthalmology. 260(7). 2291–2298. 2 indexed citations
3.
Wu, Jing, et al.. (2022). Nrf2‐Mediated Ferroptosis Inhibition Exerts a Protective Effect on Acute‐on‐Chronic Liver Failure. Oxidative Medicine and Cellular Longevity. 2022(1). 4505513–4505513. 36 indexed citations
4.
Xue, Ran, et al.. (2022). PINK1 ameliorates acute-on-chronic liver failure by inhibiting apoptosis through mTORC2/AKT signaling. Cell Death Discovery. 8(1). 222–222. 6 indexed citations
5.
Xue, Ran, Jun Zhou, Jing Wu, et al.. (2022). P-element-Induced Wimpy-Testis-Like Protein 1 Regulates the Activation of Pancreatic Stellate Cells Through the PI3K/AKT/mTOR Signaling Pathway. Digestive Diseases and Sciences. 68(4). 1339–1350. 6 indexed citations
6.
Xue, Ran, et al.. (2021). Development and Validation of a Nomogram for 90-day Outcome in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure. Journal of Clinical and Translational Hepatology. 10(3). 458–466. 8 indexed citations
7.
Xue, Ran, et al.. (2021). Novel Prognostic Models for Predicting the 180-Day Outcome for Patients with Hepatitis-B Virus-related Acute-on-chronic Liver Failure. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 4 indexed citations
8.
Xue, Ran, Juan Zhao, Juan Li, et al.. (2020). The efficacy and safety of methylprednisolone in hepatitis B virus-related acute-on-chronic liver failure: a prospective multi-center clinical trial. BMC Medicine. 18(1). 383–383. 14 indexed citations
9.
Xue, Ran, et al.. (2019). The clinical parameters for the diagnosis of hepatitis B virus related acute-on-chronic liver failure with sepsis. Scientific Reports. 9(1). 2558–2558. 7 indexed citations
10.
Zhang, Shenshen, et al.. (2019). The neuroprotective effect and action mechanism of polyphenols in diabetes mellitus-related cognitive dysfunction. European Journal of Nutrition. 59(4). 1295–1311. 29 indexed citations
11.
Xue, Ran, et al.. (2019). Mitofusin2, as a Protective Target in the Liver, Controls the Balance of Apoptosis and Autophagy in Acute-on-Chronic Liver Failure. Frontiers in Pharmacology. 10. 601–601. 21 indexed citations
12.
Xue, Ran & Qinghua Meng. (2019). The Management of Glucocorticoid Therapy in Liver Failure. Frontiers in Immunology. 10. 2490–2490. 15 indexed citations
13.
Wen, Zhengshun, et al.. (2019). Hemp seed polysaccharides protect intestinal epithelial cells from hydrogen peroxide-induced oxidative stress. International Journal of Biological Macromolecules. 135. 203–211. 46 indexed citations
14.
Xue, Ran, et al.. (2018). Mitofusin2 Induces Cell Autophagy of Pancreatic Cancer through Inhibiting the PI3K/Akt/mTOR Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2018(1). 2798070–2798070. 48 indexed citations
15.
Xue, Ran, Kai Jia, Jianxin Wang, et al.. (2018). A Rising Star in Pancreatic Diseases: Pancreatic Stellate Cells. Frontiers in Physiology. 9. 754–754. 87 indexed citations
16.
Xue, Ran, Lin Hua, Wenbin Xu, et al.. (2018). Derivation and Validation of the Potential Core Genes in Pancreatic Cancer for Tumor-Stroma Crosstalk. BioMed Research International. 2018. 1–11. 13 indexed citations
17.
Xue, Ran, et al.. (2018). Clinical performance of stem cell therapy in patients with acute-on-chronic liver failure: a systematic review and meta-analysis. Journal of Translational Medicine. 16(1). 126–126. 26 indexed citations
18.
Xue, Ran, Zhong-Hui Duan, Haixia Liu, et al.. (2017). A novel dynamic model for predicting outcome in patients with hepatitis B virus related acute-on-chronic liver failure. Oncotarget. 8(65). 108970–108980. 11 indexed citations
19.
Xue, Ran, Hui Liu, Haixia Liu, et al.. (2017). Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma. Medicine. 96(17). e6735–e6735. 23 indexed citations
20.
Zakharov, M. N., Shalender Bhasin, Thomas G. Travison, et al.. (2014). A multi-step, dynamic allosteric model of testosterone's binding to sex hormone binding globulin. Molecular and Cellular Endocrinology. 399. 190–200. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026